Early neurone loss in Alzheimer’s disease: cortical or subcortical?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259
Thal DR, Rub U, Orantes M, Braak H (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791–1800
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al (2011) Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7:280–292
Braak H, Thal DR, Ghebremedhin E, Del Tredici K (2011) Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 70:960–969
Elobeid A, Soininen H, Alafuzoff I (2012) Hyperphosphorylated tau in young and middle-aged subjects. Acta Neuropathol 123:97–104
Arendt T, Stieler J, Strijkstra AM, Hut RA, Rüdiger J, Van der Zee EA et al (2003) Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals. J Neurosci 23:6972–6981
Planel E, Richter KE, Nolan CE, Finley JE, Liu L, Wen Y et al (2007) Anesthesia leads to tau hyperphosphorylation through inhibition of phosphatase activity by hypothermia. J Neurosci 27:3090–3097
Arendt T, Bigl V, Tennstedt A, Arendt A (1984) Correlation between cortical plaque count and neuronal loss in the nucleus basalis in Alzheimer’s disease. Neurosci Lett 48:81–85
Arendt T, Bigl V, Tennstedt A, Arendt A (1985) Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer’s disease. Neurosci 14:1–14
Bigl V, Arendt T, Biesold D (1990) The nucleus basalis of Meynert during ageing and in dementing disorders. In: Steriade M, Biesold D (eds) Brain Cholinergic Systems. Oxford University Press, Oxford, pp 365–386
Struble RG, Cork LC, Whitehouse PJ, Price DL (1982) Cholinergic innervation in neuritic plaques. Science 216:413–415
Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459–496
Davies P, Maloney AJF (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 2:1403
Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1:189
Adolfsson R, Gottfries CG, Roos BE, Winblad B (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135:216–223
Cross AJ, Crow TJ, Perry EK, Perry RH, Blessed G, Tomlinson BE (1981) Reduced dopamine-beta-hydroxylase activity in Alzheimer’s disease. Br Med J 282:93–94
Francis PT, Cross AJ, Bowen DM (1994) Neurotransmitters and neuropeptides. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 247–261
Bigl V, Woolf NJ, Butcher LL (1982) Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis. Brain Res Bull 8:727–749
Wenk H, Bigl V, Meyer U (1980) Cholinergic projections from magnocellular nuclei of the basal forebrain to cortical areas in rats. Brain Res 2:295–316
Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237–1239
Arendt T, Bigl V, Arendt A, Tennstedt A (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, paralysis agitans and Korsakoff’s Disease. Acta Neuropathol 61:101–108
Mann DMA, Yates PO, Marcyniuk B (1985) Correlation between senile plaque and neurofibrillary tangle counts in cerebral cortex and neuronal counts in cortex and subcortical structures in Alzheimer’s disease. Neurosci Lett 56:51–55
Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA et al (1985) Cholinergic correlates of cognitive impairment in Parkinson’s disease: comparisons with Alzheimer’s disease. J Neurol Neurosurg Psychiatry 48:413–421
Wilcock GK, Esiri MM, Bowen DM, Smith CCT (1983) The nucleus basalis in Alzheimer’s disease: cell counts and cortical biochemistry. Neuropathol Appl Neurobiol 9:175–179
Arendt T, Bruckner MK, Bigl V, Marcova L (1995) Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer’s disease. III. The basal forebrain compared with other subcortical areas. J Comp Neurol 351:223–246
Arendt T, Brückner MK, Bigl V, Marcova L (1995) Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff’s disease, Parkinson’s disease, and Alzheimer’s disease. J Comp Neurol 351:189–222
Bondareff W, Mountjoy CQ, Roth M, Rossor MN, Iversen LL, Reynolds GP et al (1987) Neuronal degeneration in locus coeruleus and cortical correlates of Alzheimer disease. Alzheimer Dis Assoc Disord 1:256–262
Bondareff W, Mountjoy CQ, Roth M (1981) Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia. Lancet 1(8223):783–784
Burke WJ, Chung HD, Strong R, Mattammal MB, Marshall GL, Nakra R et al (1988) Mechanism of degeneration of epinephrine neurons in Alzheimer’s disease. In: Strong R, Wood WG, Burke WJ (eds) Central nervous system disorders of aging: clinical intervention and research. Raven Press, New York, pp 41–70
Busch C, Bohl J, Ohm TG (1997) Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus. Neurobiol Aging 18:401–406
Chan-Palay V, Asan E (1989) Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson’s disease with and without dementia and depression. J Comp Neurol 287:373–392
German DC, Manaye KF, White CL III, Woodward DJ, McIntire DD, Smith WK et al (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667–676
Hardy J, Adolfsson R, Alafuzoff I, Bucht G, Marcusson J, Nyberg P et al (1985) Transmitter deficits in Alzheimer’s disease. Neurochem Int 7:545–563
Hoogendijk WJG, Pool CW, Troost D, Van Zwieten E, Swaab DF (1995) Image analyser-assisted morphometry of the locus coeruleus in Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Brain 118:131–143
Ichimiya Y, Arai H, Kosaka K, Iizuka R (1986) Morphological and biochemical changes in the cholinergic and monoaminergic systems in Alzheimer-type dementia. Acta Neuropathol 70:112–116
Iversen LL, Rossor MN, Reynolds GP, Hills R, Roth M, Mountjoy CQ et al (1983) Loss of pigmented dopamine-b-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer type. Neurosci Lett 39:95–100
Mann DMA, Yates PO, Hawkes J (1982) The noradrenergic system in Alzheimer and multiinfarct dementias. J Neurol Neurosurg Psychiatry 45:113–119
Marcyniuk B, Mann DMA, Yates PO (1986) The topography of cell loss from locus caeruleus in Alzheimer’s disease. J Neurol Sci 76:335–345
Moll G, Gsell W, Wichart I, Jellinger K, Riederer P (1990) 235. In: Maurer K, Riederer P, Beckmann H (eds) Alzheimer’s disease. Epidemiology, neuropathology, neurochemistry and clinics. Springer, New York, pp 235–243
Strong R, Huang JS, Huang SS, Chung HD, Hale C, Burke WJ (1991) Degeneration of the cholinergic innervation of the locus coeruleus in Alzheimer’s disease. Brain Res 542:23–28
Tomlinson BE, Irving D, Blessed G (1981) Cell loss in the locus coeruleus in senile dementia of Alzheimer type. J Neurol Sci 49:419–428
Wilcock GK, Esiri MM, Bowen DM, Hughes AO (1988) The differential involvement of subcortical nuclei in senile dementia of Alzheimer’s type. J Neurol Neurosurg Psychiatry 51:842–849
Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ et al (1988) The neuropathology of aminergic nuclei in Alzheimer’s disease. Ann Neurol 24:233–242
Arendt T, Marcova L, Bigl V, Brückner MK (1995) Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer’s disease. I. Dendritic organisation of the normal human basal forebrain. J Comp Neurol 351:169–188
Leontovich TA, Zhukova GP (1963) The specificity of the neuronal structure and topography of the reticular formation in the brain and spinal cord of carnivora. J Comp Neurol 121:347–381
Ramon-Moliner E, Nauta WJH (1966) The isodendritic core of the brain stem. J Comp Neurol 126:311–335
Rossor MN (1981) Parkinson’s disease and Alzheimer’s disease as disorders of the isodendritic core. Br Med J 283:1588–1590
Arendt T (2000) Alzheimer’s disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. Neurobiol Aging 21:783–796
Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389–404
Corder EH, Woodbury MA, Volkmann I, Madsen DK, Bogdanovic N, Winblad B (2000) Density profiles of Alzheimer disease regional brain pathology for the huddinge brain bank: pattern recognition emulates and expands upon Braak staging. Exp Gerontol 35:851–864
Duyckaerts C, Delaère P, Hauw JJ, Abbamondi-Pinto AL, Sorbi S, Allen I et al (1990) Rating of the lesions in senile dementia of the Alzheimer type: concordance between laboratories. A European multicenter study under the auspices of EURAGE. J Neurol Sci 97:295–323
Gertz HJ, Xuereb J, Huppert F, Brayne C, McGee MA, Paykel E et al (1998) Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer’s disease. Acta Neuropathol 95:154–158
Holzer M, Gärtner U, Stöbe A, Härtig W, Gruschka H, Brückner MK et al (2002) Inverse association of Pin1 and tau accumulation in Alzheimer’s disease hippocampus. Acta Neuropathol 104:471–481
Holzer M, Holzapfel HP, Zedlick D, Brückner MK, Arendt T (1994) Abnormally phosphorylated tau protein in Alzheimer’s disease: heterogeneity of individual regional distribution and relationship to clinical severity. Neuroscience 63:499–516
Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer’s disease in individuals under thirty. Acta Neuropathol 121:171–181
Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P et al (2010) Revising the definition of Alzheimer’s disease: a new lexicon. Lancet Neurol 9:1118–1127
Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J et al (2007) Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6:734–746
Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K et al (2014) Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol 13:614–629
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer: disease: recommendations from the National Institute on Aging – Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:270–279
Jack CR Jr, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC et al (2011) Introduction to the recommendations from the National Institute on Aging – Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:257–262
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269
Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC et al (2010) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimer’s & Dementia 8:1–13
Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW et al (2012) National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach. Acta Neuropathol 123:1–11
Morris JC, Heymann A, Mohs RC et al (1989) The Consotium to Establish a Registry for Alzheimer’s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 39:1159–1165
Folstein MF, Folstein SE, McHugh PR (1975) Mini-Mental State (a practical Method for grading the state of patients for the clinician). Journal of Psychiatric Research 12:189–198
Reisberg B, Ferris SH, de Leon MJ, Crook T (1982) The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139(9):1136–1139
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140:566–572
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486
West MJ, Slomianka L, Gundersen HJ (1991) Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482–497
Arendt T, Schindler C, Brückner MK, Eschrich K, Bigl V, Zedlick D, Marcova L (1997) Plastic neuronal remodeling is impaired in patients with Alzheimer’s disease carrying apolipoprotein epsilon 4 allele. J Neurosci 17:516–529
Härtig W, Stieler J, Boerema AS, Wolf J, Schmidt U, Weissfuss J et al (2007) Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer’s disease. Eur J Neurosci 25:69–80
Bigl V, Arendt T, Fischer S, Fischer S, Werner M, Arendt A (1987) The cholinergic system in aging. Gerontology 33:172–180
Bogerts B (1981) A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker. J Comp Neurol 197:63–80
Olschewski J, Baxter D (1954) Cytoarchitecture of the human brain stem. Lippincott, Philadelphia
Amaral DG, Insausti R (1990) Hippocampal formation. In: Paxinos G (ed) The Human Nervous System. Academic Press, San Diego, pp 711–755
Insausti R, Tuñón T, Sobreviela T, Insausti AM, Gonzalo AM (1995) The human entorhinal cortex: Cytoarchitectonic analysis. J Comp Neurol 355:171–198
Hedges LV, Olkin O (1985) Statistical Methods for Meta-Analysis. Academic Press, Orlando
Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences (second ed.). Lawrence Erlbaum Associates.
McGraw KO, Wong SP (1992) A common language effect size statistic. Psychological Bulletin 111(2):361–365
Ohm TG, Busch C, Bohl J (1997) Unbiased estimation of neuronal numbers in the human nucleus coeruleus during aging. Neurobiol Aging 18:393–399
Hoogendijk WJ, Sommer IE, Pool CW, Kamphorst W, Hofman MA, Eikelenboom P et al (1999) Lack of association between depression and loss of neurons in the locus coeruleus in Alzheimer disease. Arch Gen Psychiatry 56:45–51
Lohr JB, Jeste DV (1988) Locus ceruleus morphometry in aging and schizophrenia. Acta Psychiatr Scand 77:689–697
Tomonaga M (1983) Neuropathology of the locus coeruleus: a semiquantitative study. J Neurol 230:231–240
Vijayashankar N, Brody H (1979) A quantitative study of the pigmented neurons in the nuclei locus coeruleus and subcoeruleus in man as related to aging. J Neuropathol Exp Neurol 38:490–497
Yoshinaga T (1986) Morphometric study of the human locus coeruleus: the changes with ageing and degenerative diseases. Fukuoka Igaku Zasshi 77:293–308
Gómez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease. J Neurosci 16:4491–4500
Hof PR, Bussière T, Gold G, Kfvari E, Giannakopoulos P, Bouras C et al (2003) Stereologic evidence for persistence of viable neurons in layer II of the entorhinal cortex and the CA1 field in Alzheimer disease. J Neuropathol Exp Neurol 62:55–67
Kordower JH, Chu Y, Stebbins GT, DeKosky ST, Cochran EJ, Bennett D et al (2001) Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 49:202–213
von Gunten A, Kövari E, Rivara CB, Bouras C, Hof PR, Giannakopoulos P (2005) Stereologic analysis of hippocampal Alzheimer’s disease pathology in the oldest-old: evidence for sparing of the entorhinal cortex and CA1 field. Exp Neurol 193:198–206
Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TJ (1981) Neuropathological and biochemical observations on the noradrenergic system in Alzheimer’s disease. J Neurol Sci 51:279–287
Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC (2001) Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 58:1395–1402
Lyness SA, Zarow C, Chui HC (2003) Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis. Neurobiol Aging 24:1–23
Lorenzi M, Pennec X, Frisoni GB, Ayache N (2015) Alzheimer’s Disease Neuroimaging Initiative. Disentangling normal aging from Alzheimer’s disease in structural magnetic resonance images. Neurobiol Aging. Neurobiol Aging Suppl 1:S42–S52
Jellinger K (1990) Morphology of Alzheimer’s disease and related disorders. In: Maurer K, Riederer P, Beckmann H (eds) Alzheimer’s disease. Epidemiology, neuropathology, neurochemistry, and clinics. Springer, New York, pp 61–77
Geula C, Mesulam M-M (1994) Cholinergic systems and related neuropathological predilection patterns in Alzheimer disease. In: Terry RD, Katzman R, Bick KL (eds) Alzheimer disease. Raven Press, New York, pp 263–291
Mann DM, Yates PO, Marcyniuk B (1984) A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 47:201–203
Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337–341
Förstl H, Levy R, Burns A, Luthert P, Cairns N (1994) Disproportionate loss of noradrenergic and cholinergic neurons as cause of depression in Alzheimer’s disease - a hypothesis. Pharmacopsychiatry 27:11–15
Syed A, Chatfield M, Matthews F, Harrison P, Brayne C, Esiri MM (2005) Depression in the elderly: pathological study of raphe and locus ceruleus. Neuropathol Appl Neurobiol 31:405–413
Braak H, Del Tredici K (2012) Where, when, and in what form does sporadic Alzheimer’s disease begin? Curr Opin Neurol 25:708–714
Attems J, Thal DR, Jellinger KA (2012) The relationship between subcortical tau pathology and Alzheimer’s disease. Biochem Soc Trans 40:711–715